Results 251 to 260 of about 13,757,225 (358)

A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma

Cancer Communications, EarlyView.
Jin‐Seong Hwang, Sugi Lee, Gyeonghwa Kim, Hoibin Jeong, Kiyoon Kwon, Eunsun Jung, Yuna Roh, Taesang Son, Hana Lee, Moo‐Seung Lee, Kyoung‐Jin Oh, Hye Won Lee, Yu Rim Lee, Soo Young Park, Won Young Tak, Hyun Seung Ban, Hyun‐Soo Cho, Mi‐Young Son, Jang‐Seong Kim, Keun Hur, Dae‐Soo Kim, Tae‐Su Han   +21 more
wiley   +1 more source

Tislelizumab: Structural Innovations and Expanding Clinical Horizons in Next‐Generation PD‐1 Immunotherapy

Chronic Diseases and Translational Medicine, EarlyView.
The interaction of tislelizumab with PD‐1/PD‐L1 in the tumor microenvironment. Tislelizumab targets PD‐1 on T cells, blocking its interaction with PD‐L1 on tumor cells. This action is facilitated by a modified F(ab) region that limits Fc‐γ receptor binding, thereby enhancing the antitumor immune response. ABSTRACT Tislelizumab is a next‐generation PD‐1
Thy T. Nguyen, Bohan Zhang, Luke Zhong, Xiuyi Liang, Letao Bo   +4 more
wiley   +1 more source

Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue. [PDF]

Pathogens
Panão-Costa J, Oliveira RC, Teixeira P, Caramelo F, Cipriano MA, Borges O, Carvalho A.   +6 more
europepmc   +1 more source

Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients

, 1970
Kamrun Nahar, Munira Jahan, Afzalun Nessa, S Tabassum   +3 more
openalex   +2 more sources

Asymmetric Total Synthesis of (−)‐Glycybridin B, a Pharmacophore Screened Candidate for Tubulin Binding

Chemistry – A European Journal, EarlyView.
Discovery and first total synthesis of (−)‐glycybridin B via a five‐step route utilizing a key chalcone intermediate. Initially identified through a pharmacophore screening as a potential tubulin binder, this natural product serves as a tool compound to explore structure‐activity relationships related to microtubule targeting and anticancer potential ...
Alice Maiocchi, Maxim Shevelev, Zlata Boiarska, Juan Estévez‐Gallego, Francesca Bonato, Paolo Orlando, Alessandra Chinosi, Emanuele Marcone, Andrea Citarella, Dragos Horvath, Michel O. Steinmetz, Andrea E. Prota, Alexandre Varnek, Valerio Fasano, Daniele Passarella   +14 more
wiley   +1 more source

Role of Common Fractalkine Receptor Variants with Chronic Hepatitis B Patients in Tunisia. [PDF]

Viruses
Ben Dhifallah I, Ayouni K, Belaiba Z, Razgui BA, Trabelsi S, Touzi H, Sadraoui A, Hammemi W, Hannachi H, Kebir A, Ben Miled S, Triki H.   +11 more
europepmc   +1 more source

Harnessing Viral Proteases for Cellular and Molecular Engineering

Chemistry–Methods, EarlyView.
Engineered viral proteases (VIPs) provide programmable control of protein function with high specificity and low toxicity. Integrated with chemogenetic and optogenetic modules, these VIP systems enable logic gate manipulation for targeted regulation of cell signaling, gene expression, protein secretion, and degradation, thereby offering versatile ...
Mingguang Cui, Tien‐Hung Lan, Yubin Zhou   +2 more
wiley   +1 more source

Eliminating perinatal transmission of hepatitis B virus: it is time for action

Journal of the International AIDS Society
Rania A. Tohme, Su Wang, Benjamin Cowie, Sandra Dudareva, Carolyn Wester   +4 more
doaj   +1 more source